A Comparison of Two Dose Levels of Indinavir Combined With Two Nucleoside Analogue Reverse Transcriptase Inhibitors (NRTIs) in HIV-Infected Patients
Clinical trial NCT00002406 · COMPLETED
Trial details
- NCT number
- NCT00002406
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Enrollment
- 350
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.